VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 87 filers reported holding VAXCYTE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,472,157 | -10.7% | 499,650 | -12.5% | 2.35% | -25.9% |
| Q2 2023 | $28,528,225 | +100.2% | 571,250 | +50.2% | 3.17% | +114.8% |
| Q1 2023 | $14,251,770 | -23.4% | 380,250 | -2.0% | 1.48% | -44.7% |
| Q4 2022 | $18,602,203 | +130.9% | 387,950 | +15.6% | 2.67% | +143.7% |
| Q3 2022 | $8,056,000 | -0.1% | 335,650 | -9.4% | 1.10% | -13.0% |
| Q2 2022 | $8,065,000 | +1.7% | 370,650 | +12.9% | 1.26% | +23.0% |
| Q1 2022 | $7,930,000 | +13.1% | 328,350 | +11.4% | 1.02% | +45.7% |
| Q4 2021 | $7,012,000 | -22.3% | 294,750 | -17.1% | 0.70% | -50.1% |
| Q3 2021 | $9,023,000 | +6.7% | 355,650 | -5.3% | 1.41% | +8.2% |
| Q2 2021 | $8,456,000 | +45.8% | 375,650 | +27.9% | 1.30% | +24.4% |
| Q1 2021 | $5,800,000 | – | 293,650 | – | 1.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $82,124,000 | 28.36% |
| Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $37,277,000 | 21.71% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,405,421 | $27,757,000 | 8.90% |
| FRAZIER MANAGEMENT LLC | 2,309,554 | $45,614,000 | 3.66% |
| RA Capital Management | 3,865,808 | $76,350,000 | 1.15% |
| TPG Group Holdings (SBS) Advisors, Inc. | 4,558,475 | $90,030,000 | 1.05% |
| Soleus Capital Management, L.P. | 293,650 | $5,800,000 | 1.04% |
| Opaleye Management Inc. | 357,800 | $7,067,000 | 1.04% |
| SABBY MANAGEMENT, LLC | 178,992 | $3,535,000 | 0.69% |
| Penn Mutual Asset Management, LLC | 22,227 | $439,000 | 0.50% |